Julie R. Gralow, MD
Chief Medical Officer and Executive Vice President, American Society of Clinical Oncology
- Internationally known breast medical oncologist, clinical trialist, and advocate for people with breast cancer
- Previously, Jill Bennett Endowed Professor of breast medical oncology and professor of global health at the University of Washington School of Medicine
- Founder, Women's Empowerment Cancer Advocacy Network (WE CAN)
Julie R. Gralow, MD, is the Chief Medical Officer and Executive Vice President of the American Society of Clinical Oncology. She previously served as the Jill Bennett Endowed Professor of Breast Medical Oncology and professor of global health at the University of Washington School of Medicine, was a member of the clinical research division at the Fred Hutchinson Cancer Research Center, and was director of breast medical oncology at the Seattle Cancer Care Alliance.
Dr. Gralow is internationally known for her breast cancer clinical care, education, and research. She has conducted local and national clinical trials related to breast cancer treatment, prevention, and survivorship. Her main area of research specialization is understanding the relationship between breast cancer and the bone environment.
Dr. Gralow was executive officer for breast and lung cancer for the SWOG National Clinical Trials Network and co-founder and team physician of Team Survivor Northwest, an exercise and fitness program for women cancer survivors. She is founder of the Women’s Empowerment Cancer Advocacy Network (WE CAN), a group dedicated to empowering women cancer patient advocates in low and middle income countries.
Breast cancer treatment during the coronavirus outbreak
Drs. Julie Gralow and Reshma Mahtani explain how people in treatment for breast cancer can balance the known threat of breast cancer against what was known about the potential threat of developing COVID-19 in the first few months of the pandemic.